Immune and inflammatory signaling pathways

Immune and inflammatory signaling pathways represent the complex, interconnected biochemical networks that coordinate cellular responses to infection, injury, and environmental stress. These pathways, including the NF-κB, JAK-STAT, and MAPK cascades, utilize a variety of receptors and signaling proteins to translate extracellular signals into specific genomic responses (Source: Nature Reviews Immunology, 2021). While essential for host defense and tissue homeostasis, their aberrant or chronic activation is a fundamental driver of autoimmune disorders, chronic inflammatory diseases, and cancer progression (Source: StatPearls, 2023). In the context of drug discovery, these pathways are not targeted in their entirety; instead, specific molecular components such as cytokines, kinases, or receptors are selected as therapeutic targets to modulate the immune response (Source: NIH, 2022). Consequently, this term serves as a broad biological classification rather than a single, discrete molecular target for pharmacological intervention. Therapeutic agents interacting with these pathways include a wide range of biologics and small molecules designed to inhibit specific nodes, thereby reducing pathological inflammation (Source: PubMed, PMID: 30272095). However, the broad nature of these signaling networks often presents challenges in achieving specificity without compromising the patient's overall immune competence.

Other names

Immune signaling cascadesInflammatory response pathwaysImmunological signalingInflammatory signaling

Modulation of various signaling nodes within the immune and inflammatory cascades, including cytokine inhibition, kinase blockade, and transcription factor regulation.